XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th Profit Margin

The latest profit margin for XOMAO is 64.89% as of March 2026. That compares with -7.82% in the prior-year period — up 929.3% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's historical trend and sector peers before judging valuation or financial health.

Over the past year, XOMAO's profit margin moved from -7.82% to 64.89% — a 929.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's valuation or profitability profile.

Against Healthcare companies, XOMAO currently prints 64.89% for profit margin, while the sector average sits near 13.89%. That is roughly 367.1% above the sector mean. Large gaps often invite a closer look at XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's growth, margins, and balance sheet.

Profit Margin shows how effectively XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th converts resources into returns. At 64.89%, XOMAO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -7.82% in the prior-year period — up 929.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting XOMAO's profit margin (64.89%), review year-over-year change from -7.82%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.